Global Blood Cell Separator Market 2024-2030

    In Stock

    BLOOD CELL SEPARATOR MARKET

     

    KEY FINDINGS

    1. A blood cell separator is a medical device that separates whole blood into its different components, such as red blood cells, white blood cells, platelets, and plasma.
    2. This process is called apheresis. There are two main types of blood cell separators, Centrifugal blood cell separators and Filtration blood cell separators.
    3. The market is driven by the increasing demand for blood cell separation procedures in various medical applications, including transfusion medicine, regenerative medicine, and oncology.
    4. The apheresis segment is expected to be the fastest-growing segment during the forecast period, due to the increasing adoption of apheresis procedures for the collection of stem cells, platelets, and other blood components.
    5. The increasing prevalence of chronic diseases, such as cancer and autoimmune diseases, which require blood cell separation procedures, can be a market key driver.
    6. The high cost of blood cell separators, which can limit their adoption in developing countries is the major challenge for Blood cell separator market.
    7. The global shortage of blood donations is creating opportunities for companies that develop blood cell separator products that can be used to collect more blood components from a single donor.
    8. There is a growing demand for blood cell separator products that can be used at the point of care. This would allow for faster and more convenient blood cell separation procedures
    9. Governments across the globe have established regulatory frameworks to oversee the development, manufacturing, and distribution of blood cell separators. These frameworks aim to guarantee the safety and effectiveness of these devices for patients.
    10. Governments raise awareness about blood cell separation procedures among patients and healthcare providers. These campaigns highlight the benefits of these procedures and encourage their adoption in clinical settings.

     

    BLOOD CELL SEPARATOR MARKET OVERVIEW

    North America is expected to remain the largest market for blood cell separators during the forecast period. Asia-Pacific is expected to be the fastest-growing market, due to the increasing demand for blood cell separation procedures in developing countries in the region. Europe is expected to experience steady growth, driven by the aging population and the increasing prevalence of chronic diseases.

     

    Stringent regulatory requirements for blood cell separators, which can delay the introduction of new products to the market. There is a growing demand for new and innovative blood cell separator products. This includes products that are more efficient, user-friendly, and portable. There is also a demand for products that can collect specific blood components, such as stem cells and platelets.

     

    Regulatory agencies, such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA), conduct rigorous assessments of blood cell separator products to ensure they meet stringent quality and performance standards.

     

    Governments provide financial support for research and development activities in blood cell separator technology. This funding fosters innovation and the development of novel technologies that address unmet medical needs. Governments collaborate with international organizations to promote harmonization of regulatory standards and share best practices in blood cell separator technology. This collaboration facilitates global access to safe and effective technologies.

     

    The United States Food and Drug Administration (FDA) has granted breakthrough therapy designation for several blood cell separator technologies, accelerating their development and review process.

     

    The European Medicines Agency (EMA) has published guidelines for the evaluation of blood cell separator products, providing clarity for manufacturers and ensuring consistent regulatory standards across Europe. 

     

    The Chinese government has invested heavily in the development of domestic blood cell separator technologies, aiming to reduce reliance on imported devices and strengthen the country’s position in the global market.

     

    INTRODUCTION TO THE BLOOD CELL SEPARATOR MARKET

    Blood is spun in a centrifuge to separate your plasma, platelets, and red blood cells. The heavier red blood cells drop to the bottom when the blood is separated and are returned to you. 

     

    The separator may be used to process blood from banks in bulk or, with the addition of certain monitoring tools, to process donor blood right away. The device draws blood, fractionates it, and returns the plasma and, if requested, the erythrocyte fraction to the user.

     

    An automated blood cell separator is a machine that draws whole blood from a donor using a centrifugal or filtration separation rule. Blood cell separators are used to collect specific blood components for a variety of medical purposes, including Transfusion medicine, Regenerative medicine, and Oncology.

     

    Blood cell separators are also used to treat a variety of other medical conditions, such as Autoimmune diseases and sickle cell disease. An uncommon blood condition known as PNH, or Paroxysmal Nocturnal Hemoglobinuria, causes red blood cells to fragment.

     

    Hemolysis is the medical term for this disintegrating. It occurs as a result of a person’s blood cells’ surface lacking a protein that shields them from the immunological system of the body. The heavier red blood cells drop to the bottom when the blood is separated and are returned to you. Between the liquid plasma and the platelets are tracked into a tiny pouch that is wrapped around the centrifuge cylinder as the liquid plasma rises.

     

    Blood cell separators can be used to collect specific blood components, such as red blood cells, platelets, and plasma, for transfusion to patients who need them. This can help to improve patient outcomes by providing them with the blood components they need to recover from surgery, trauma, or other medical conditions. 

     

    It can be used to collect blood components that are specifically matched to the patient’s blood type. This can help to reduce the risk of transfusion-related complications, such as hemolytic reactions.

     

    BLOOD CELL SEPARATOR MARKET SIZE AND FORECAST

    Infographics: Blood Cell Separator Market , Blood Cell Separator Market Size, Blood Cell Separator Market Trends, Blood Cell Separator Market Forecast, Blood Cell Separator Market Risks, Blood Cell Separator Market Report, Blood Cell Separator Market Share

    The Global Blood Cell Separator market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

     

    TRENDS IN BLOOD CELL SEPARATOR MARKET

     

    • Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and blood disorders, is a major driver of demand for blood cell separator procedures. These diseases often require the collection of specific blood components, such as stem cells, platelets, and plasma, for treatment.
    • Technological Advancements: Technological advancements in blood cell separator technology are making these devices more efficient, user-friendly, and portable. This is leading to wider adoption of blood cell separators in various clinical settings. For example, the development of miniaturized blood cell separators is making these devices more accessible to smaller hospitals and clinics.
    • Personalized Medicine: The trend towards personalized medicine is also driving demand for blood cell separators. Blood cell separators can be used to collect customized blood components for specific patients, based on their individual needs.
    • Shortage of Blood Donations: The global shortage of blood donations is another factor driving the growth of the blood cell separator market. Blood cell separators can be used to collect more blood components from a single donor, which can help to alleviate the shortage.
    • Emerging Markets: Emerging markets are expected to be a major driver of growth in the blood cell separator market. This is due to the increasing prevalence of chronic diseases and the growing adoption of personalized medicine in these markets.
    • Government Policies: Government policies play a significant role in shaping the global blood cell separator market by influencing factors such as demand, supply, and innovation. This includes providing funding for research and development, expanding reimbursement coverage, and promoting public awareness.

     

    BLOOD CELL SEPARATOR MARKET NEW PRODUCT LAUNCH

     

    • Fresenius Medical Care has launched a new blood cell separator called the Amia. The Amia is a compact and easy-to-use device that is designed for use in smaller hospitals and clinics.
    • Haemonetics Corporation has announced the development of a new plasma exchange therapy product called PlasmaRite. PlasmaRite is a sterile, ready-to-use product that is designed to simplify the plasma exchange process.
    • Terumo Corporation has launched a new apheresis device called the Trima Accell. The Trima Accell is a high-volume apheresis device that is designed to increase the collection of blood components.
    • Baxter International Inc. has announced the expansion of its manufacturing facility for blood cell separators in Singapore. The expansion will increase the company’s production capacity by 50%.
    • Beckman Coulter Inc. has launched a new software program for its blood cell separators called the NexSys Connect. NexSys Connect is a cloud-based software program that allows healthcare providers to remotely monitor and manage their blood cell separators.

     

    BLOOD CELL SEPARATOR MARKET SEGMENTATION

     

    By Product

    • Consumables (reagents, kits, beads)
    • Instruments (centrifuges, flow cytometers, filtration systems)

     

    By Cell Type

    • Human cells
    • Animal cells

     

    By Technique

    • Centrifugation-based cell isolation
    • Surface marker-based cell isolation
    • Filtration-based cell isolation

     

    By End-Users

    • Research laboratories & institutes
    • Hospitals
    • Biotechnology & bio pharmaceutical companies
    • Others (blood banks, cell therapy centers)

     

    By Region

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

     

    BLOOD CELL SEPARATOR MARKET COMPANY PROFILED

    • Fresenius Kabi (Germany)
    • Terumo Corporation (Japan)
    • Haemonetics Corporation (USA)
    • Nihon Kohden Corporation (Japan
    • Beckman Coulter, Inc. (USA)

     

    BLOOD CELL SEPARATOR MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. How many Blood Cell Separators are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. How is the increasing prevalence of chronic diseases impacting the demand for blood cell separators?
    3. In what ways are technological advancements in blood cell separator technology leading to wider adoption of these devices?
    4. How is the growing awareness of blood cell separation procedures among patients and healthcare providers affecting the demand for these procedures?
    5. Cost breakup of a  Global Blood Cell Separator and key vendor selection criteria.
    6. Where is the Blood Cell Separator manufactured? What is the average margin per unit?
    7. Market share of Global Blood Cell Separator manufacturers and their upcoming products.
    8. Cost advantage for OEMs who manufacture Global Blood Cell Separator in-house.
    9. 5 key predictions for the next 5 years in the Global Blood Cell Separator market.
    10. Average B-2-B Blood Cell Separator price in all segments.
    11. Latest trends in the Blood Cell Separator market, by every market segment.
    12. The market size (both volume and value) of the Blood Cell Separator  2024-2030 and every year in between?
    13. Production breakup of Blood Cell Separator by suppliers and their OEM relationship.
     
    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Research Methodology
    4 Executive Summary
    5 Average B2b Price, By Region
    06 Potential Opportunities For Client
    7 Introduction
    8 Insights from Industry stakeholders
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Specific challenges and considerations related to implementing Global Blood Cell Separator systems.
    14 Advantages and obstacles associated with the use of Global Blood Cell Separator in healthcare.
    15 The role of Global Blood Cell Separator in remote patient monitoring and telehealth initiatives.
    16 New product development in past 12 months
    17 Market Size, Dynamics and Forecast by Geography, 2024-2030
    18 Market Size, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Size, Dynamics and Forecast by Application, 2024-2030
    20 Market Size, Dynamics and Forecast by Technology, 2024-2030
    21 Competitive Landscape
    22 M&A in past 12 months
    23 Growth strategy of leading players
    24 Market share of vendors, 2023
    25 Company Profiles
    26 Unmet needs and opportunity for new suppliers
    27 Conclusion
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop